radiation proctopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Primary cervical adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma was confirmed by pathology; 2. Patients with stage IIB to stage IV clinical staging . 3. The patients had good hematopoiesis and hepatorenal function: leukocyte > 4 x 10^9 / L; platelet > 100 x 10^9 / L; creatinine < 2.0 mg / dl; bilirubin < 1.5 times of normal value; glutamic pyruvate transaminase and glutamic oxaloacetate transaminase < 3 times of normal value; 4. Patients can tolerate surgery in general; 5. Patients sign informed consent; 6. Patients with a history of cancer but no evidence of recurrence for more than 5 years can be selected; 7. Female patients aged 18 and above.
Exclusion criteria
Exclusion criteria: 1. Any pathological type other than adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma; 2. FIGO stage is from IA1 to iia2; 3. The patient has a history of pelvic or abdominal radiotherapy; 4. The subjects had a history of inflammatory bowel disease or colorectal surgery; 5. Pregnancy; 6. Not suitable for operation: serious systemic diseases are not suitable for this study; 7. Poor compliance or inability to follow up due to geographical factors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of radiation proctopathy; | — |
Countries
China
Contacts
The First Affiliated Hospital of Sun Yat-Sen University